Stocks
Ono Pharmaceutical Co., Ltd.OPHLY
OTCHealthcareBiotechnology$4.88+1.24%
Price as of · delayed, not real-time
A Japan-based pharmaceutical firm focused on developing and commercializing innovative drugs, particularly in oncology and immunology. Investors monitor Ono Pharmaceutical for its pipeline of specialty treatments and partnerships with global biopharma companies.
Market Cap: $6.9B52W Range: $3.28 – $5.75
Congressional Interest in Ono Pharmaceutical Co., Ltd. (OPHLY)
2 members of Congress have disclosed 4 trades in Ono Pharmaceutical Co., Ltd. (OPHLY), a Healthcare company. The buy/sell breakdown shows 1 purchase versus 3 sales, indicating net selling pressure from lawmakers. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
Total Disclosures
4
Unique Politicians
2
Buys
1
Sells
3
Who in Congress Is Trading OPHLY?
| Date | Politician | Type | Amount |
|---|---|---|---|
| 2023-07-10 | Daniel Goldman | sell | $1K – $15K |
| 2012-04-10 | MICHAEL T. MCCAUL | sell | $15K – $50K |
| 2012-01-10 | MICHAEL T. MCCAUL | sell | $1K – $15K |
| 2009-01-05 | MICHAEL T. MCCAUL | buy | $1K – $15K |